T. Younis

The Cost Burden of Trastuzumab and Bevacizumab Therapy for Solid Tumours in Canada

Arik Drucker, Chris Skedgel, Kiran Virik et al. · Current Oncology · 2008 · 48 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Wait times for breast cancer care

Nathalie Saint‐Jacques, T. Younis, Ron Dewar et al. · British Journal of Cancer · 2006 · 39 citations · Full text

Medicine, Oncology, Breast Oncology +14

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Nab-Paclitaxel Therapy

Nathan Lamond, T. Younis, Kerri Purdy et al. · Current Oncology · 2013 · 34 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

Chris Skedgel, Daniel Rayson, Ron Dewar et al. · Breast Cancer Research and Treatment · 2006 · 32 citations

Pharmacy, Oncology, Pharmacoeconomics +14

The Cost–Utility of Adjuvant Chemotherapy Using Docetaxel and Cyclophosphamide Compared with Doxorubicin and Cyclophosphamide in Breast Cancer

T. Younis, Daniel Rayson, Chris Skedgel · Current Oncology · 2011 · 32 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17